BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 3)

Drug-resistant gonorrhea: Rapid and cheap assay can provide real-time surveillance

By

By NewsDesk  @bactiman63 A dual therapy treatment regimen of expanded-spectrum cephalosporins (ESCs) plus azithromycin (AZM) is the recommended standard of care for gonorrhea. A strain of the Neisseria...

COVID-19

Remdesivir receives FDA approval for the treatment of COVID-19

By

The U.S. Food and Drug Administration (FDA) today approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms...

Boston biotech joins COVID-19 antibody treatment effort

By

Abpro Corporation announced it has completed dosing all subjects in a Phase 1 clinical trial evaluating the safety of ABP 300, a human neutralizing antibody for the treatment of COVID-19 derived from patients...

Cidara announces new data from IDWeek 2020

By

Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced...

TB

TB treatment: New shorter regimen identified in trial

By

By NewsDesk  @bactiman63 Results from an international, randomized, controlled clinical trial indicate that a four-month daily treatment regimen containing high-dose, or “optimized,” rifapentine...

Ebola: FDA approves Inmazeb, 1st treatment for the virus

By

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola...

Candida: NDA submitted to the FDA for antifungal drug representing a new class in over 20 years

By

Biotechnology company, SCYNEXIS, Inc. today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for oral ibrexafungerp for the treatment of vulvovaginal...

Cryptosporidium treatment: Repurposed anti-malarial compounds kill parasite, study finds

By

A class of compounds used for malaria treatment also kill the intestinal parasite Cryptosporidium, a leading cause of diarrheal disease and death in children that has no cure, a multi-institution collaboration...

Antibiotics: FETROJA receives FDA approval for for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

By

Shionogi & Co., Ltd. Monday announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for FETROJA ® (cefiderocol) for the treatment of patients...

Potential hand, foot and mouth disease drug candidate identified

By

A study appearing next week in the journal Nature Communications offers some good news in the search for antiviral drugs for hard-to-treat diseases. Researchers have identified a potential new drug candidate...